Development of a multi faceted platform containing a tetrazine, fluorophore and chelator: synthesis, characterization, radiolabeling, and immuno-SPECT imaging

Overview of attention for article published in EJNMMI Radiopharmacy and Chemistry, June 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 16 Mendeley

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 583 followers.

RT @CaterinaRamogi1: Just out in EJNMMI R&C: https://t.co/iySANgazLt Our work on developing multi-modal platforms for theranostics. Congra…

Reply Repost Favourite

RT @CaterinaRamogi1: Just out in EJNMMI R&C: https://t.co/iySANgazLt Our work on developing multi-modal platforms for theranostics. Congra…

Reply Repost Favourite

Just out in EJNMMI R&C: https://t.co/iySANgazLt Our work on developing multi-modal platforms for theranostics. Congrats Anthony, @Brooke_L_McNeil et al!

Reply Repost Favourite